N=5 though.
More similar to impaired glycolysis than to PDH deficiency.
I don't understand why Fluge and Mella did not test directly for the PDH acivity in PMBC of their patients. In the mouse study I mentioned above they tested for the PDH activity, for instance.
@Snow Leopard https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282483/
I was searching pubmed for articles on lithium and mTor when I came across this article. It talks about lithium activating GPCR I believe, although it is over my head. Perhaps it's of value to you? I plan on using lithium when I start a mini Ketamine trial, for their synergy on mTor activation.
If you're looking for an metabolism-Immune-B Cell nexus that could be indicated by low ceramides, this is one. (Of course, I'm not a boichemist, maybe such nexuses are a dime a dozen.)
Did you look at the methods of the mouse study in detail? They killed the mice and took tissue samples.
I don't know if you have already observed in some previous post that a metabolic alteration similar to the one depicted by Fluge and colleagues in ME/CFS, has been described in mice infected with influenza A virus, during the first 7 days of infection (Yamane K et al. 2014). In that study they found a decrease in PDH activity, a depletion of ATP in tissues, and an increase in PDK4 expression.
As antibodies are not produced during the first week after an infection, this PDH disfunction is due to other factors than autoantibodies.
Yes, I know. Is not possible to perform the same test on peripheral blood mononuclear cells (PBMC)?
The PDH dysfunction in the Yamane study is obviously due to factors other than autoantibodies. But that does not eliminate the possibility that an autoantibody could disrupt endocrine/autocrine signalling that also potentially leading to the PDH dysfunction observed.
If you want to test the functioning of an enzyme (in a somewhat similar environment to how it would function in your body) you really need a tissue sample. It might be possible to do with biopsies (they say they used ~1 mg protein per well), but it isn't easy to get patients willing to donate multiple biopsies.
I am discussing this study with a biologist. If there is a casual relationship in the findings why doesn't the disease severity and the biochemistry correlate?
did the selenium ever correlate to any dizziness for you? I have taken it randomly in small amounts along with molybdenum in liquid form per Rich V's advice in the past. This year I started taking them both daily, just a few drops, in smoothies and it coincided with lightheaded/nausaea/dizziness increasing and when I stopped taking it the symptoms decreased significantly-seems the selenium from my various trials was the culprit. Had never noticed sensitivity to it in the past until took it regularly, but things change over the years on what I can tolerate randomly too.When my virus induced chronic recurrent body-wide paresthesias (pins and needles), that lasted for around 9 years (typically getting worse after exercise, and possibly a sign of some neuropathy), benfotiamine was one of the few treatments that had a (temporary) impact on this symptom.
Since 2012, though, when I started taking high dose selenium and N-acetyl-glucosamine every day (and have taken these daily ever since), I have not had any recurrence of my viral paresthesias.
I am discussing this study with a biologist. If there is a casual relationship in the findings why doesn't the disease severity and the biochemistry correlate?
Now we all know that chronic coxsackievirus B infections of the skeletal muscles are linked to ME/CFS, but it is not clear how such infections could cause the autoimmunity that Fluge and Mella found in ME/CFS, nor the energy metabolism dysfunctions that MBM, Fluge and Mella, and other research groups have found.
But that single CVB myocarditis study could be the link: it could explain how these 3 observed facets of ME/CFS — the viral infection, the autoimmunity, and the energy metabolism dysfunction — all tie together to create a Grand Unifying Theory of ME/CFS:
CVB infection ➤ triggers translocator protein autoantibodies ➤ which whack the mitochondria ➤ leading to ME/CFS
It seems unlikely, to me, that a CVB infection could be the initial trigger to everyone's me/cfs. From my understanding there are a wide variety of infections that trigger me/cfs. For me, and others, it was obviously an ebv (and resulting mono) infection that was the initial trigger.
Furthermore, a wide variety of infectious triggers points to the actual trigger of me/cfs being the response to the infection, rather than the infection proper.
Lastly, anyone experimenting with specific drugs, eg DCA be very careful! DCA is noted to have substantial side effects in some patients.
Disclaimer: I don't condone this sort of self-experimentation
When I ran my 23andme results through Promethease, it came up with this;
https://www.snpedia.com/index.php/Gs311
Is there any literature suggesting that mycotoxins inhibit this process in the way it is being described? I ask because a lot of cfs patients report mold avoidance and or treatment has made them feel better.
... at least in the literature where every specialist thinks (from their viewpoint) that what they are an expert in is the central most important part of a complex system. Nails always look like the central feature when you're a hammer.